Definium Therapeutics Inc (DFTX) PT Raised to $72 at Wells Fargo
August 13, 2026 8:42 AM
Wells Fargo analyst Benjamin Burnett raised the price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $72.00 (from $68.00) while maintaining a Overweight rating.
